Published on
May 17, 2022
- 11:00 GMT
Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
ROCHESTER, MINNESOTA, UNITED STATES, May 17, 2022 /EINPresswire.com/ -- Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced $29.5M in new funding led by Mr. Harry …
Distribution channels:
Agriculture, Farming & Forestry Industry, Business & Economy
...
